Total Payments
$113,984
2024 Payments
$7,877
Companies
34
Transactions
498
Medicare Patients
2,526
Medicare Billing
$209,754
Payment Breakdown by Category
Other$70,710 (62.0%)
Consulting$20,588 (18.1%)
Food & Beverage$12,929 (11.3%)
Travel$9,626 (8.4%)
Education$131.38 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,710 | 27 | 53.3% |
| Consulting Fee | $20,588 | 7 | 18.1% |
| Food and Beverage | $12,929 | 408 | 11.3% |
| Honoraria | $10,000 | 3 | 8.8% |
| Travel and Lodging | $9,626 | 45 | 8.4% |
| Education | $131.38 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $54,928 | 76 | $0 (2019) |
| Amgen Inc. | $23,323 | 46 | $0 (2023) |
| DERMIRA, INC. | $10,617 | 10 | $0 (2019) |
| Merz North America, Inc. | $8,146 | 29 | $0 (2023) |
| ABBVIE INC. | $7,844 | 94 | $0 (2024) |
| Allergan, Inc. | $2,795 | 17 | $0 (2022) |
| Medline Industries, Inc. | $928.34 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $721.92 | 21 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $530.77 | 31 | $0 (2024) |
| Galderma Laboratories, L.P. | $441.14 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,877 | 72 | ABBVIE INC. ($6,841) |
| 2023 | $1,304 | 66 | ABBVIE INC. ($253.61) |
| 2022 | $3,303 | 88 | Amgen Inc. ($1,627) |
| 2021 | $11,369 | 49 | Amgen Inc. ($10,658) |
| 2020 | $11,479 | 48 | Amgen Inc. ($10,885) |
| 2019 | $35,769 | 81 | Celgene Corporation ($24,127) |
| 2018 | $17,413 | 49 | Celgene Corporation ($14,407) |
| 2017 | $25,468 | 45 | Celgene Corporation ($16,393) |
All Payment Transactions
498 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/12/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology | ||||||
| 12/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $88.37 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $5,462.50 | General |
| 10/18/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $45.92 | General |
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Dermatology | ||||||
| 09/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $402.53 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $206.98 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $156.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/19/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Inflammation & Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Immunology | ||||||
| 09/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 725 | 1,304 | $205,771 | $54,259 |
| 2022 | 10 | 626 | 1,293 | $205,149 | $50,955 |
| 2021 | 12 | 570 | 974 | $209,690 | $57,109 |
| 2020 | 12 | 605 | 1,137 | $207,354 | $47,430 |
Total Patients
2,526
Total Services
4,708
Medicare Billing
$209,754
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 214 | $45,325 | $13,831 | 30.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 112 | 141 | $39,626 | $11,957 | 30.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 119 | 162 | $33,374 | $6,175 | 18.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 62 | 78 | $17,853 | $5,429 | 30.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 78 | 108 | $14,863 | $4,740 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $14,455 | $4,094 | 28.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 19 | 23 | $10,672 | $2,945 | 27.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 84 | 486 | $21,887 | $2,635 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $3,722 | $1,074 | 28.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 17 | $2,135 | $719.94 | 33.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,859 | $660.88 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 195 | $38,466 | $13,009 | 33.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 86 | 106 | $28,087 | $9,103 | 32.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 112 | 161 | $35,234 | $6,413 | 18.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 26 | 33 | $15,378 | $4,734 | 30.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $21,996 | $4,316 | 19.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 52 | 57 | $12,129 | $4,251 | 35.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 62 | 79 | $10,531 | $3,523 | 33.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 91 | 616 | $35,849 | $3,396 | 9.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $5,676 | $1,648 | 29.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $1,804 | $562.23 | 31.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 114 | 151 | $29,611 | $11,020 | 37.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 81 | 99 | $26,208 | $9,211 | 35.1% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2021 | 18 | 25 | $40,143 | $7,813 | 19.5% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 12 | 12 | $19,824 | $7,111 | 35.9% |
About Dr. Te Hsu, MD
Dr. Te Hsu, MD is a Dermatology healthcare provider based in Itasca, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255300042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Te Hsu, MD has received a total of $113,984 in payments from pharmaceutical and medical device companies, with $7,877 received in 2024. These payments were reported across 498 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($60,710).
As a Medicare-enrolled provider, Hsu has provided services to 2,526 Medicare beneficiaries, totaling 4,708 services with total Medicare billing of $209,754. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Itasca, IL
- Active Since 03/15/2006
- Last Updated 10/10/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1255300042
Products in Payments
- Otezla (Drug) $75,013
- QBREXZA (Drug) $10,617
- RHOFADE (Drug) $2,391
- BOTOX (Biological) $1,334
- XEOMIN (Biological) $1,228
- COSENTYX (Biological) $612.86
- SKYRIZI (Biological) $561.54
- Xeomin (Biological) $425.61
- DUPIXENT (Biological) $419.66
- ILUMYA (Biological) $351.51
- EUCRISA (Drug) $262.34
- OPZELURA (Drug) $252.39
- TALTZ (Drug) $241.95
- VTAMA (Drug) $237.66
- Bimzelx (Biological) $224.88
- RINVOQ (Biological) $206.23
- TREMFYA (Drug) $162.98
- ADBRY (Biological) $153.38
- Humira (Biological) $138.21
- Sotyktu (Drug) $122.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.